THC Therapeutics Risk Adjusted Performance

THCT Stock  USD 0.0005  0.00  0.00%   
THC Therapeutics risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for THC Therapeutics or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
THC Therapeutics has current Risk Adjusted Performance of 0.086.

RAP

 = 

(ER[a] - RFR) * STD[b])/STD[b]

RFR

 = 
0.086
ER[a] = Expected return on investing in THC Therapeutics
RFR = Risk Free Rate of return. Typically T-Bill Rate
STD[b] =   Standard Deviation of selected market or benchmark.

THC Therapeutics Risk Adjusted Performance Peers Comparison

THC Risk Adjusted Performance Relative To Other Indicators

THC Therapeutics is rated second in risk adjusted performance category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about  10,339  of Maximum Drawdown per Risk Adjusted Performance. The ratio of Maximum Drawdown to Risk Adjusted Performance for THC Therapeutics is roughly  10,339 
Compare THC Therapeutics to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas